17.24MMarket Cap-1255P/E (TTM)
1.090High1.060Low157.76KVolume1.070Open1.060Pre Close169.56KTurnover1.00%Turnover RatioLossP/E (Static)15.97MShares2.74052wk High2.80P/B16.98MFloat Cap0.86052wk Low--Dividend TTM15.72MShs Float323999.370Historical High--Div YieldTTM2.85%Amplitude0.860Historical Low1.074Avg Price1Lot Size
Microbot Medical Stock Forum
Benzinga-Second Site In Company's Pivotal Human Clinical Trial, Following Brigham & Women's Hospital, Supporting Future FDA Submission For Commercialization
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
Microbot Medical (Nasdaq: MBOT) announced the successful enrollment of the first patient in its pivotal human clinical trial for the LIBERTY® Endovascular Robotic Surgical System. The procedure was conducted at Brigham and Women’s Hospital (BWH) in Boston, led by Dr. Dmitry Rabkin. This trial, part of an Investigational Device Exemption (IDE), aims to gather data to support the future ...
3 MINUTES AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE
Microbot Medical Partners With Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
No comment yet